Chitosan nanoparticles as adenosine carriers

Journal of Microencapsulation

Volumn 32, Issue 5, 2015, Pages 460-466

  Kazemzadeh Narbat, Mehdi ^a,b,c   Reid, Marla ^a   Brooks, Marianne Su Ling ^a   Ghanem, Amyl ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Adenosine; chitosan; drug delivery systems; nanoparticles

Indexed keywords

ADENOSINE; CHITOSAN NANOPARTICLE; DRUG CARRIER; CHITOSAN; DELAYED RELEASE FORMULATION; NANOPARTICLE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; GELATION; IN VITRO STUDY; ISOELECTRIC POINT; MEDICAL RESEARCH; NANOENCAPSULATION; PARTICLE SIZE; SPECTROPHOTOMETRY; STEADY STATE; SURFACE CHARGE; CHEMISTRY; DELAYED RELEASE FORMULATION; PHARMACOKINETICS;

ADENOSINE; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; NANOPARTICLES;

EID: 84938847190     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2015.1046517     Document Type: Article

References (39)

1. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release, 2004; 100: 5-28
2. Berne RM. The role of adenosine in the regulation of coronary blood flow. Circ Res, 1980; 47: 807-13
3. Calvo P, Remunãn-López C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci, 1997; 63: 125-32
4. Drury AN, Szent-Györgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol, 1929; 68: 213-37
5. Dunwiddie TV. Adenosine and suppression of seizures. Adv Neurol, 1999; 79: 1001-10
6. Forman MB, Stone GW, Jackson EK. Role of adenosine as adjunctive therapy in acute myocardial infarction. Cardiovascul Drug Rev, 2006; 24: 116-47
7. Gan Q, Wang T, Cochrane C, McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Coll Surfaces B Biointerf, 2005; 44: 65-73
8. Ganguly K, Chaturvedi K, More UA, Nadagouda MN, Aminabhavi TM. Polysaccharide-based micro/nanohydrogels for delivering macromolecular therapeutics. J Control Release, 2014; 193: 162-73
9. Gao G, Lange D, Hilpert K, Kindrachuk J, Zou Y, Cheng JT, Kazemzadeh-Narbat M, Yu K, Wang R, Straus SK, et al. The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides. Biomaterials, 2011; 32: 3899-909
10. Goldberg M, Langer R, Jia XQ. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed, 2007; 18: 241-68
11. Grenha A. Chitosan nanoparticles: A survey of preparation methods. J Drug Target, 2012; 20: 291-300
12. Hasko G, Cronstein BN. Adenosine: An endogenous regulator of innate immunity. Trends Immunol, 2004; 25: 33-9
13. Ishida O, Maruyama K, Sasaki K, Iwatsuru M. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int J Pharm, 1999; 190: 49-56
14. Kazemzadeh-Narbat M. 2013. Local delivery of antimicrobial peptides from titanium surface for the prevention of implant-associated infections. Doctoral dissertation, Retrieved from the University of British Columbia
15. Kazemzadeh-Narbat M, Kindrachuk J, Duan K, Jenssen H, Hancock RE, Wang R. Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections. Biomaterials, 2010; 31: 9519-26
16. Kazemzadeh-Narbat M, Lai BF, Ding C, Kizhakkedathu JN, Hancock RE, Wang R. Multilayered coating on titanium for controlled release of antimicrobial peptides for the prevention of implant-associated infections. Biomaterials, 2013; 34: 5969-77
17. Kazemzadeh-Narbat M, Noordin S, Masri BA, Asri BA, Garbuz DS, Duncan CP, Hancock RE, Wang R. Drug release and bone growth studies of antimicrobial peptide loaded calcium phosphate coating on titanium. J Biomed Mater Res B Appl Biomater, 2012; 100: 1344-52
18. Kazemzadeh-Narbat M, Wang Q, Hancock RE, Wang R. Antimicrobial peptide delivery from trabecular bone grafts. J Biomater Tissue Eng, 2014; 4: 967-72
19. Kean T, Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev, 2010; 62: 3-11
20. Kumar M. A review of chitin and chitosan applications. Reactive Funct Polym, 2000; 46: 1-27
21. Lopez-Leon T, Carvalho EL, Seijo B, Ortega-Vinuesa JL, Bastos-Gonzalez D. Physicochemical characterization of chitosan nanoparticles: Electrokinetic and stability behavior. J Coll Interface Sci, 2005; 283: 344-51
22. Ma M, Kazemzadeh-Narbat M, Hui Y, Lu S, Ding C, Chen D, Hancock RE, Wang R. Local delivery of antimicrobial peptides using self organized TiO 2 nanotube arrays for peri-implant infections. J Biomed Mater Res A, 2012; 100: 278-85
23. Pagonopoulou O, Efthimiadou A, Asimakopoulos B, Nikolettos NK. Modulatory role of adenosine and its receptors in epilepsy: Possible therapeutic approaches. Neurosci Res, 2006; 56: 14-20
24. Paidas CN, Dudgeon DL, Haller JA, Clemens MG. Adenosine triphosphate (ATP) treatment of hypoxic pulmonary hypertension (HPH): Comparison of dose dependence in pulmonary and renal circulations. J Surg Res, 1989; 46: 374-9
25. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue, Adv Drug Deliv Rev, 2003; 55: 329-47
26. Qiu LY, Bae YH. Polymer architecture and drug delivery. Pharm Res, 2006; 23: 1-30
27. Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov, 2004; 3: 785-96
28. Rampino A, Borgogna M, Blasi P, Bellich B, Cesàro A. Chitosan nanoparticles: Preparation, size evolution and stability. Int J Pharm, 2013; 455: 219-28
29. Rudzinski WE, Aminabhavi TM. Chitosan as a carrier for targeted delivery of small interfering RNA. Int J Pharm, 2010; 399: 1-11
30. Sadeghi AM, Dorkoosh FA, Avadi MR, Saadat P, Rafiee-Tehrani M, Junginger HE. Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods. Int J Pharm, 2008; 355: 299-306
31. Sawynok J, Liu XJ. Adenosine in the spinal cord and periphery: Release and regulation of pain. Progr Neurobiol, 2003; 69: 313-40
32. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release, 2001; 70: 1-20
33. Takahama H, Minamino T, Asanuma H, Fujita M, Asai T, Wakeno M, Sasaki H, Kikuchi H, Hashimoto K, Oku N, et al. Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats. J Am Coll Cardiol, 2009; 53: 709-17
34. U.S. Food and Drug Administration. 2013. FDA warns of rare but serious risk of heart attack and death with cardiac nuclear stress test drugs Lexiscan (regadenoson) and Adenoscan (adenosine)
35. U.S. Food and Drug Administration. Adenocard IV (adenosine injection) for rapid bolus intravenous use
36. U.S. Food and Drug Administration. Adenoscan® (adenosine injection) for intravenous infusion only
37. Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for controlled drug release. Chem Rev, 1999; 99: 3181-98
38. Zhang H, Oh M, Allen C, Kumacheva E. Monodisperse chitosan nanoparticles for mucosal drug delivery. Biomacromolecules, 2004; 5: 2461-8
39. Zhou S, Deng X, Li X. Investigation on a novel core-coated microspheres protein delivery system. J Control Release, 2001; 75: 27-36